Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole Observational Study for H. Pylori
NCT00216450Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2004
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of rabeprazole in Helicobacter pylori infection, sponsored by Janssen Pharmaceutical. Primary endpoint: Incidence of adverse events at 6 months. Started Oct 2004; status: completed.
02
Drugs
rabeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT00216450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216450.